Search

everythinglearnresearchcommunity

for

Search:↓

The growth of the Chamaecyparis obtusa trees in Gyeongnam Province, South Korea, was evaluated.

Feed restriction in sheep leads to finer wool fibers but may reduce wool quality.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Certain genes control the color of human hair by affecting pigment production.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Melatonin affects mouse skin and may regulate skin functions.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Melatonin helps grow more secondary hair follicles in young goats, improving cashmere production.

Blue light might help treat skin conditions by affecting the skin's bacteria.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Deer antler stem cell fluid helps regenerate tissue better than fat-derived stem cell fluid.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Melatonin implants did not effectively prevent hair loss in dogs.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.